Fajnkuchen, Franck
Pieramici, Dante
Hrarat, Linda
Best, Anne-Laurence
Cohen, Salomon Y.
Delahaye-Mazza, Corinne
Grenet, Typhaine
Nghiem-Buffet, Sylvia
Quentel, Gabriel
Bodaghi, Bahram
Giocanti-Aurégan, Audrey http://orcid.org/0000-0002-7918-7845
Funding for this research was provided by:
AVOPH
Article History
Received: 25 April 2018
Accepted: 9 August 2018
First Online: 28 August 2018
Compliance with ethical standards
:
: Dr. Franck Fajnkuchen, Dr. Sylvia Nghiem-Buffet, and Dr. Audrey Giocanti-Aurégan report having received personal fees from Novartis, Bayer, Allergan, outside the scope of the submitted work. Dr. Dante Pieramici is consultant for Genentech, Regeneron, Thrombogenics, Novartis, and reports having received research Genentech, Regeneron, Ophthea, Regenerative Patch, RegenX Bio, Clearside Biomedical. Dr. Typhaine Grenet reports having received personal fees from Novartis, Bayer, outside the scope of the submitted work. Dr. Linda Hrarat, Dr. Anne-Laurence Best, Dr. Corinne Delahaye-Mazza and Prof. Bodaghi have nothing to disclose. Dr. Gabriel Quentel reports having received personal fees from Novartis outside the scope of the submitted work. Prof. Salomon Y. Cohen reports having received personal fees from Novartis, Bayer, Allergan, Alcon, Thea, outside the scope of the submitted work.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
: Informed consent was obtained from all patients for being included in the study.